Cannabinoids for Tourette's Syndrome

Muller-Vahl, 2002, Treatment of Tourette's syndrome with Delta-9-tetrahydrocannabinol (THC): A randomidsed crossover trial, Pharmacopsychiatry, 35, 57, 10.1055/s-2002-25028

Muller-Vahl, 2003, Delta-9-tetrahydrocannabinol is effective in the treatment of tics in Tourette syndrome: A 6 week randomised trial, Journal of Clinical Psychiatry, 64, 459, 10.4088/JCP.v64n0417

Muller-Vahl, 2001, Influence of Treatment with D9-THC on Neuropsychological Performance, Pharmacopsychiatry, 34, 19, 10.1055/s-2001-15191

Muller-Vahl, 2001, Influence of treatment with delta-9-tetrahydrocannabinol on neuropsychological performance, Pharmacopsychiatry, 34, 19, 10.1055/s-2001-15191

Muller-Vahl, 2003, Treatment of Tourette Syndrome with Delta-(-Tetrahydrocannabinol (D9-THC): No Influence on Neuropsychological Performance, Neuropsychopharmacology, 28, 384, 10.1038/sj.npp.1300047

Cohen, 2001, Advances in Neurology, 85

Baker, 2003, The therapeutic potential of cannabis, The Lancet Neurology, 2, 291, 10.1016/S1474-4422(03)00381-8

Bruggeman, 2001, Risperidone versus pimozide in Tourette's disorder: a comparative double blind parallel- group study, Journal of Clinical Psychiatry, 62, 50, 10.4088/JCP.v62n0111

Chappell, 1995, The pharmacological treatment of tic disorders, Child and adolescent Psychiatric Clinic of North America, 4, 197, 10.1016/S1056-4993(18)30457-7

Dion, 2002, Risperidone in the Treatment of Tourette Syndrome: A double blind placebo controlled trial, Journal of Clinical Psychopharmacology, 22, 31, 10.1097/00004714-200202000-00006

AMERICAN PSYCHIATRIC ASSOCIATION, 1994, DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS

Gaffney, 2002, Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome, Journal of the American Acadamy of Child and Adolescent psychiatry, 41, 330, 10.1097/00004583-200203000-00013

Gancher, 1990, Treatment of Tourette Syndrome with transdermal clonidine: a pilot study, Journal of Neuropsychiatry and Clinical Neurosciences, 2, 66, 10.1176/jnp.2.1.66

Goetz, 1987, Clonidine and Gilles de la Tourette Syndrome: Double blind study using objective rating methhods, Annals of neurology, 21, 307, 10.1002/ana.410210313

Hemming, 1993, Effective treatment of Tourette's syndrome with marijuana, Journal of Psychopharmacology, 7, 389, 10.1177/026988119300700411

Johns, 2001, Psychiatric effects of cannabis, British Journal of psychiatry, 178, 116, 10.1192/bjp.178.2.116

Matsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038/346561a0

Matsuda, 1993, Localisation of cannabinoid receptor mRNA in rat brain, Journal of comparative neurology., 327, 535, 10.1002/cne.903270406

McDougle, 1994, A double blind placebo controlled study in patients with and without tics, Archives of General Psychiatry, 51, 302, 10.1001/archpsyc.1994.03950040046006

Moher, 2001, The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials, The Lancet, 357, 1191, 10.1016/S0140-6736(00)04337-3

Muller-Vahl, 1998, Cannabinoids: Possible role in the patho-physiology and therapy in Tourette syndrome, Acta Psychiatrica Scandinavia, 98, 502, 10.1111/j.1600-0447.1998.tb10127.x

Munro, 1993, Molecular characterisation of a peripheral receptor for cannabinoids, Nature, 365, 61, 10.1038/365061a0

Romero, 2002, The endogenous cannabinoid system and the basal ganglia: Biochemical, pharmacological, and therapeutic aspects, Pharmacology and Therapeutics, 95, 137, 10.1016/S0163-7258(02)00253-X

Ross, 1978, A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome, American Journal of Psychiatry, 135, 585, 10.1176/ajp.135.5.585

Sandyk, 1988, Marijuana and Tourette's syndrome, Journal of Clinical Psychopharmacology, 8, 444, 10.1097/00004714-198812000-00021

Shapiro, 1984, Controlled study of pimozide vs. placebo in Tourette's Syndrome, Journal of the American Academy of Child Psychiatry, 23, 161, 10.1097/00004583-198403000-00007

Shapiro, 1989, Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourettes's Syndrome, Archives of General Psychiatry, 46, 722, 10.1001/archpsyc.1989.01810080052006

Thomas, 1996, A community survey of the adverse effects of cannabis use, Drug and alcohol dependence, 42, 201, 10.1016/S0376-8716(96)01277-X

The Tourette's Syndrome Study Group, 2002, Treatment of ADHD in children with tics: A randomized controlled trial, Neurology, 58, 527, 10.1212/WNL.58.4.527

Walkup, May 1992, The validity of instruments measuring tic severity in Tourette's syndrome, Journal of the American Academy of Child & Adolescent Psychiatry, 31, 472, 10.1097/00004583-199205000-00013